CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Opthea Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Sep 15, 2025
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Opthea Ltd income statement
Ratios
Latest available, balances at Jun 30, 2025
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -623048.0%
- Net margin
- -651164.0%
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.22
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 18.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –